Biocept Inc (BIOCQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,614 | -18,399 | -16,950 | -15,866 | -9,233 |
| Depreciation Amortization | 576 | 322 | 261 | 251 | 267 |
| Accounts receivable | -1,065 | -95 | -24 | -1 | 10 |
| Accounts payable and accrued liabilities | 350 | 333 | -52 | -982 | -175 |
| Other Working Capital | 145 | 749 | 70 | -2,416 | 598 |
| Other Operating Activity | 1,957 | 1,394 | 1,539 | 4,438 | 2,332 |
| Operating Cash Flow | $-19,651 | $-15,697 | $-15,155 | $-14,576 | $-6,202 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,400 | -451 | -165 | -395 | -1 |
| Investing Cash Flow | $-1,400 | $-451 | $-165 | $-395 | $-1 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 5,263 | 1,981 |
| Debt Issued | 13,656 | N/A | N/A | 175 | 4,245 |
| Debt Repayment | -166 | -86 | -75 | -23 | N/A |
| Common Stock Issued | 7,499 | 13,771 | 19,548 | 17,390 | 20 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -4 |
| Other Financing Activity | -2,400 | -1,749 | -697 | -2,538 | -155 |
| Financing Cash Flow | $18,588 | $11,937 | $18,777 | $20,266 | $6,087 |
| Beginning Cash Position | 4,609 | 8,821 | 5,365 | 69 | 185 |
| End Cash Position | 2,147 | 4,609 | 8,821 | 5,365 | 69 |
| Net Cash Flow | $-2,463 | $-4,212 | $3,457 | $5,295 | $-116 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,651 | -15,697 | -15,155 | -14,576 | -6,202 |
| Capital Expenditure | -1,400 | -482 | -165 | -395 | -1 |
| Free Cash Flow | -21,051 | -16,179 | -15,320 | -14,971 | -6,203 |